I don't think anyone can provide an example but I'd love to see anybody willing to try & I will make very generous concessions to try and ease an approach.
Any company below $50M MC or what the heck below $100M would still struggle to find a comparative.
> $9M Cash
> 2x Phase II
> FDA / EMA Orphan Drug Designation (even 1 is adequate)
> Big Pharma / Big Biotech partner
Even just two of the above will do
lets play a little exercise
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 4291214 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 600160 | 2 |
View Market Depth
| Last trade - 16.12pm 09/09/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable